KARINA MARQUEZ: Open Payments
NPI 1013588565 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 34 payments from 16 companies in 2025. Trend: 2023 $318 · 2024 $370 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 5 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| Amgen Inc. | 4 | $58 |
| Novo Nordisk Inc | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| RGH Enterprises LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| ACADIA Pharmaceuticals Inc | 2 | $37 |
| Exact Sciences Corporation | 1 | $29 |
| Lilly USA, LLC | 1 | $26 |
Products named: JARDIANCE, TZIELD, BREZTRI, OTEZLA, Rybelsus, Kerendia, DAYBUE, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
